The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jeevan Krishna Kuchipudi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jeevan Krishna Kuchipudi, part of the promoter group of Jeevan Scientific Technology Ltd, acquired 6,00,000 (six lakh) convertible warrants through a preferential issue on January 2, 2026. Before this acquisition, the promoter held 78,500 shares (0.49% of voting capital). After the acquisition, total holding stands at 6,78,500 units (78,500 shares + 6,00,000 warrants), representing 2.90% on a fully diluted basis and 0.39% on a non-diluted basis. The company's equity share capital expanded from Rs.15.83 crore (1.58 crore shares of Rs.10 each) to Rs.19.92 crore (1.99 crore shares) as a result of the preferential allotment. Snigdha Mothukuri, Promoter and Executive Director, signed the disclosure letter dated January 6, 2026.
This is a positive signal as the promoter is putting fresh money into the company via warrants, reflecting insider confidence. However, the promoter's voting shareholding post-allotment remains very small (0.39%), so the absolute impact on shareholder composition is limited though the move strengthens the promoter group's position over time.